Pay in 4 interest-free payments of $6.43 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
(The paper absorbs moisture.) You should also wash them straight before using, because they wont last as long when stored damp
Regulatory hurdles: Approval for novel indications (Alzheimers, neurodegenerative diseases) requires very high bar: long follow-ups, clinically meaningful endpoints, safety
The loop works in both directions
Perjeta (pertuzumab) Disease area(s): Oncology Manufacturer(s): Roche 2024 Sales (USD): $4.11 billion Why it sold so well: Roches Perjeta generated global sales of CHF 3.62 billion ($4.11 billion) last year, maintaining its position as a key therapy in HER2-positive breast cancer
PMCID: PMC11472427
US$ 24.70
US$ 23.74
US$ 26.73
US$ 20.41
US$ 29.05
